Zydus receives USFDA approval to begin Phase III trial of sickle cell anaemia treatement drug with ICMR

Zydus receives USFDA approval to begin Phase III trial of sickle cell anaemia treatement drug with ICMR

Zydus Lifesciences on Thursday, July 23, said it has received approval to begin a Phase III clinical trial of its investigational drug Desidustat for treating anaemia in patients with sickle cell disease (SCD), in collaboration with the Indian Council of Medical Research (ICMR). The 203-day, double-blind, randomised, placebo-controlled, parallel, multicentre study will enrol 164 patients…

Read More
Emmer Capital keeps India allocation intact despite oil price risks, backs private banks

Emmer Capital keeps India allocation intact despite oil price risks, backs private banks

Rising crude oil prices and geopolitical tensions in the Middle East have increased uncertainty for global markets, but Emmer Capital Partners is not cutting its exposure to India. Instead, the investment firm believes investors should remain selective and focus on sectors where earnings are improving, while continuing to favour private sector banks over the long…

Read More